CMND 1.49 Clearmind Medicine Inc.
| Range: | 0.921-6.8 | Vol Avg: | 360178 | Last Div: | 0 | Changes: | 0.44 |
| Beta: | -1.48 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Tue Nov 15 2022 | Empoloyees: | 4 | ||
| CUSIP: | CIK: | 0001892500 | ISIN: | CA1850534027 | Country: | CA | |
| CEO: | Dr. Adi Zuloff-Shani Ph.D. | Website: | https://www.clearmindmedicine.com | ||||
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow